Furthermore, SerpinA3 has been implicated in tumour invasiveness and increased epithelial to mesenchymal transition (EMT) via regulation of EMT markers E-cadherin, N-cadherin vimentin and EZH2 in an in-vitro model of triple-negative breast cancers [75]. The gene discussed is SERPINA3; the disease is neoplasm.